Loading cancer entity…
Loading cancer entity…
Clinical trials
10,628 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,642)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00482716 | Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer | unknown | Phase 3 | 80 | St. Bartholomew's HospitalOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT01210287 | Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP(IHBVRL) | unknown | Phase 2 / Phase 3 | 110 | Fudan UniversityOTHER | 1 | Jan 8, 2014 |
| clinicaltrials |
| NCT02024815 | Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma. | unknown | Phase 3 | 100 | Lithuanian University of Health SciencesOTHER | 1 | Dec 31, 2013 | clinicaltrials |
| NCT00003423 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | unknown | Phase 3 | 100 | United Kingdom Children's Cancer Study GroupOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00020865 | Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia | unknown | Phase 3 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00022685 | Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma | unknown | Phase 3 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002987 | Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease | unknown | Phase 3 | 400 | Medical Research CouncilOTHER_GOV | 2 | Dec 4, 2013 | clinicaltrials |
| NCT00003421 | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease | completed | Phase 3 | 800 | Medical Research CouncilOTHER_GOV | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00017290 | Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma | unknown | Phase 3 | — | Genitope CorporationINDUSTRY | 2 | Dec 4, 2013 | clinicaltrials |
| NCT01998503 | Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis | completed | Phase 3 | 56 | Nanjing University School of MedicineOTHER | 1 | Nov 29, 2013 | clinicaltrials |
| NCT00205751 | Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy | completed | Phase 2 / Phase 3 | 350 | Austrian Forum Against CancerOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00205764 | Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy | completed | Phase 3 | 212 | Austrian Forum Against CancerOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01355783 | A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma | withdrawn | Phase 3 | 0 | Eisai Inc.INDUSTRY | 1 | Nov 18, 2013 | clinicaltrials |
| NCT01110824 | Prevention of Left Ventricular Dysfunction During Chemotherapy(OVERCOME) | completed | Phase 3 | 90 | Hospital Clinic of BarcelonaOTHER | 1 | Nov 15, 2013 | clinicaltrials |
| NCT00070187 | Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma | completed | Phase 2 / Phase 3 | 24 | Children's Oncology GroupNETWORK | 3 | Oct 17, 2013 | clinicaltrials |
| NCT00003578 | High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma | unknown | Phase 3 | 500 | Lymphoma Trials OfficeOTHER | 4 | Sep 20, 2013 | clinicaltrials |
| NCT00006250 | Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma | unknown | Phase 3 | 500 | Lymphoma Trials OfficeOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00041210 | Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | unknown | Phase 3 | 850 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00003639 | Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma | unknown | Phase 3 | 200 | Scotland and Newcastle Lymphoma GroupOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00003815 | Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | unknown | Phase 3 | — | Scotland and Newcastle Lymphoma GroupOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00005589 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | completed | Phase 3 | 460 | EBMT Solid Tumors Working PartyOTHER | 17 | Sep 17, 2013 | clinicaltrials |
| NCT00016887 | Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | unknown | Phase 3 | — | German Low Grade Lymphoma Study GroupOTHER | 2 | Sep 17, 2013 | clinicaltrials |
| NCT00025636 | Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma | unknown | Phase 3 | 220 | German Hodgkin's Lymphoma Study GroupOTHER | 8 | Sep 17, 2013 | clinicaltrials |
| NCT00028691 | Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma | unknown | Phase 3 | — | Commissie Voor Klinisch Toegepast OnderzoekOTHER | 3 | Sep 17, 2013 | clinicaltrials |
| NCT00028717 | Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma | unknown | Phase 3 | 400 | Commissie Voor Klinisch Toegepast OnderzoekOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00002827 | Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease | completed | Phase 3 | 294 | Children's Oncology GroupNETWORK | 3 | Aug 26, 2013 | clinicaltrials |
| NCT00608374 | Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma | completed | Phase 3 | 400 | Taunton and Somerset HospitalOTHER | 2 | Aug 26, 2013 | clinicaltrials |
| NCT00005977 | Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | completed | Phase 3 | 83 | Children's Oncology GroupNETWORK | 6 | Aug 21, 2013 | clinicaltrials |
| NCT00934154 | Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma | completed | Phase 3 | 122 | Cigdem Sahinbas YILMAZINDUSTRY | 1 | Aug 15, 2013 | clinicaltrials |
| NCT00012051 | Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | completed | Phase 3 | 340 | Commissie Voor Klinisch Toegepast OnderzoekOTHER | 2 | Aug 12, 2013 | clinicaltrials |
| NCT00445497 | Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia | unknown | Phase 3 | 400 | Clatterbridge Centre for OncologyOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00002576 | Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma | completed | Phase 3 | 200 | Cancer Research Campaign Clinical Trials CentreOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00003924 | Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma | unknown | Phase 3 | 360 | Lymphoma Study AssociationOTHER | 2 | Aug 7, 2013 | clinicaltrials |
| NCT00005590 | Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 3 | — | Cancer Research Campaign Clinical Trials CentreOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00089115 | Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma | terminated | Phase 3 | — | FavrilleINDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00480363 | QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression(QUIREDEX) | completed | Phase 3 | 120 | PETHEMA FoundationOTHER | 1 | Jul 31, 2013 | clinicaltrials |
| NCT00275106 | Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma | terminated | Phase 3 | 600 | Children's Cancer and Leukaemia GroupOTHER | 3 | Jul 10, 2013 | clinicaltrials |
| NCT00003341 | Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy | completed | Phase 3 | 275 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00352846 | Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss | completed | Phase 3 | 135 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00005867 | Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | completed | Phase 3 | 310 | Lymphoma Trials OfficeOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00090493 | Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma | completed | Phase 2 / Phase 3 | 4 | University of ArkansasOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003150 | Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma | completed | Phase 3 | 630 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00002700 | Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | completed | Phase 3 | 392 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Jun 12, 2013 | clinicaltrials |
| NCT01230983 | Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma(T-Cell #4) | completed | Phase 3 | 573 | Children's Oncology GroupNETWORK | 0 | Jun 6, 2013 | clinicaltrials |
| NCT00002556 | Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma | completed | Phase 3 | 312 | National Cancer Institute (NCI)NIH | 1 | May 31, 2013 | clinicaltrials |
| NCT01801436 | A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma | completed | Phase 3 | 14 | Johnson & Johnson Taiwan LtdINDUSTRY | 0 | May 16, 2013 | clinicaltrials |
| NCT00006708 | S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | terminated | Phase 3 | 7 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00002742 | Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer | completed | Phase 3 | — | Aronex PharmaceuticalsINDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT01188798 | Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies | completed | Phase 3 | 6 | St. Jude Children's Research HospitalOTHER | 1 | Mar 21, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jan 10, 2014source: clinicaltrials